Nianli Sang

4.4k total citations
57 papers, 3.6k citations indexed

About

Nianli Sang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Nianli Sang has authored 57 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 25 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Nianli Sang's work include Cancer, Hypoxia, and Metabolism (20 papers), Cancer-related Molecular Pathways (11 papers) and Ubiquitin and proteasome pathways (9 papers). Nianli Sang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (20 papers), Cancer-related Molecular Pathways (11 papers) and Ubiquitin and proteasome pathways (9 papers). Nianli Sang collaborates with scholars based in United States, China and Italy. Nianli Sang's co-authors include Antonio Giordano, J. Jaime, Vickram Srinivas, Shuyang Chen, Dongming Liang, Xianguo Kong, Shuo Qie, Xavier Graña, О. H. Minchenko and Daniel P. Stiehl and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular and Cellular Biology.

In The Last Decade

Nianli Sang

56 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nianli Sang United States 32 2.5k 1.5k 969 485 298 57 3.6k
Margaret Ashcroft United Kingdom 34 3.2k 1.3× 1.7k 1.2× 1.7k 1.8× 361 0.7× 318 1.1× 58 4.6k
Athanassios Kotsinas Greece 25 2.8k 1.1× 702 0.5× 1.4k 1.5× 431 0.9× 431 1.4× 70 3.9k
Narendra Wajapeyee United States 31 2.7k 1.1× 941 0.6× 895 0.9× 283 0.6× 274 0.9× 95 3.7k
Fiona Kaper United States 18 2.6k 1.1× 2.2k 1.5× 780 0.8× 349 0.7× 186 0.6× 24 4.1k
Georgia Sotiropoulou Greece 37 1.7k 0.7× 1.1k 0.7× 1.1k 1.1× 301 0.6× 429 1.4× 92 4.1k
Maurizio Fanciulli Italy 32 2.8k 1.1× 821 0.6× 1.1k 1.2× 338 0.7× 256 0.9× 115 4.0k
Agata Giallongo Italy 25 2.1k 0.8× 1.4k 1.0× 418 0.4× 381 0.8× 183 0.6× 49 3.3k
Michelle Barton United States 46 4.6k 1.9× 1.0k 0.7× 1.0k 1.1× 568 1.2× 327 1.1× 109 5.7k
Marco Crescenzi Italy 37 3.3k 1.3× 645 0.4× 1.3k 1.3× 474 1.0× 433 1.5× 116 4.5k

Countries citing papers authored by Nianli Sang

Since Specialization
Citations

This map shows the geographic impact of Nianli Sang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nianli Sang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nianli Sang more than expected).

Fields of papers citing papers by Nianli Sang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nianli Sang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nianli Sang. The network helps show where Nianli Sang may publish in the future.

Co-authorship network of co-authors of Nianli Sang

This figure shows the co-authorship network connecting the top 25 collaborators of Nianli Sang. A scholar is included among the top collaborators of Nianli Sang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nianli Sang. Nianli Sang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Junping, Dylan Frabutt, Patrick L. Mulcrone, et al.. (2022). Subgenomic particles in rAAV vectors result from DNA lesion/break and non-homologous end joining of vector genomes. Molecular Therapy — Nucleic Acids. 29. 852–861. 17 indexed citations
2.
Qie, Shuo & Nianli Sang. (2022). Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target. Journal of Experimental & Clinical Cancer Research. 41(1). 161–161. 52 indexed citations
3.
Lin, Bing, Yinting Chen, Yinping Huang, et al.. (2020). Gender differences in UV-induced skin inflammation, skin carcinogenesis and systemic damage. Environmental Toxicology and Pharmacology. 81. 103512–103512. 31 indexed citations
4.
Qie, Shuo, Qiaojuan Guo, Shuyang Chen, et al.. (2019). <p>Stanniocalcin 2 (STC2) expression promotes post-radiation survival, migration and invasion of nasopharyngeal carcinoma cells</p>. Cancer Management and Research. Volume 11. 6411–6424. 26 indexed citations
5.
Simic, Damir & Nianli Sang. (2019). Compounds targeting class II histone deacetylases do not cause panHDACI-associated impairment of megakaryocyte differentiation. Experimental Hematology. 72. 36–46. 2 indexed citations
6.
Hu, Tu, et al.. (2015). DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas. Journal of Experimental & Clinical Cancer Research. 34(1). 22–22. 35 indexed citations
7.
Lin, Abraham, Billy Truong, Arthur M. Pappas, et al.. (2015). Uniform Nanosecond Pulsed Dielectric Barrier Discharge Plasma Enhances Anti‐Tumor Effects by Induction of Immunogenic Cell Death in Tumors and Stimulation of Macrophages. Plasma Processes and Polymers. 12(12). 1392–1399. 94 indexed citations
8.
Lin, Shaojun, Qiaojuan Guo, Chao Li, et al.. (2014). Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas. Journal of Experimental & Clinical Cancer Research. 33(1). 26–26. 33 indexed citations
9.
Li, Weihua, Yanhong Tai, Jie Zhou, et al.. (2012). Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis. Cell Cycle. 11(12). 2348–2358. 62 indexed citations
10.
Yin, Chengqian, Shuo Qie, & Nianli Sang. (2012). Carbon Source Metabolism and Its Regulation in Cancer Cells. Critical Reviews in Eukaryotic Gene Expression. 22(1). 17–35. 53 indexed citations
11.
Meng, Meng, Shuyang Chen, Taotao Lao, Dongming Liang, & Nianli Sang. (2010). Nitrogen anabolism underlies the importance of glutaminolysis in proliferating cells. Cell Cycle. 9(19). 3921–3932. 73 indexed citations
12.
Stiehl, Daniel P., Donna M. Fath, Dongming Liang, Yubao Jiang, & Nianli Sang. (2007). Histone Deacetylase Inhibitors Synergize p300 Autoacetylation that Regulates Its Transactivation Activity and Complex Formation. Cancer Research. 67(5). 2256–2264. 50 indexed citations
13.
Kong, Xianguo, Lin Zhao, Dongming Liang, et al.. (2006). Histone Deacetylase Inhibitors Induce VHL and Ubiquitin-Independent Proteasomal Degradation of Hypoxia-Inducible Factor 1α. Molecular and Cellular Biology. 26(6). 2019–2028. 219 indexed citations
14.
Liang, Dongming, Xianguo Kong, & Nianli Sang. (2006). Effects of Histone Deacetylase Inhibitors on HIF-1. Cell Cycle. 5(21). 2430–2435. 70 indexed citations
15.
Severino, Anna, Alfonso Baldi, Giuliano Cottone, et al.. (2003). RACK1 is a functional target of the E1A oncoprotein. Journal of Cellular Physiology. 199(1). 134–139. 12 indexed citations
16.
Sang, Nianli, et al.. (2003). MAPK Signaling Up-regulates the Activity of Hypoxia-inducible Factors by Its Effects on p300. Journal of Biological Chemistry. 278(16). 14013–14019. 301 indexed citations
17.
Sang, Nianli. (2002). Adenoviral E1A everlasting tool versatile applications continuous contributions and new hypotheses. Frontiers in bioscience. 7(4). d407–413. 25 indexed citations
18.
Sang, Nianli, Pier Paolo Claudio, Yan Fu, et al.. (1997). Transforming Region of 243 R E1A Contains Two Overlapping but Distinct Transactivation Domains. DNA and Cell Biology. 16(11). 1321–1333. 7 indexed citations
19.
Sang, Nianli & Antonio Giordano. (1997). Extreme N terminus of E1A oncoprotein specifically associates with a new set of cellular proteins. Journal of Cellular Physiology. 170(2). 182–191. 15 indexed citations
20.
Sang, Nianli, et al.. (1995). Cyclins, Cyclin-Dependent Kinases and Cdk Inhibitors: Implications in Cell Cycle Control and Cancer. Critical Reviews in Eukaryotic Gene Expression. 5(2). 127–156. 278 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret Ashcroft Breakdown of academic impact, for papers by Athanassios Kotsinas Breakdown of academic impact, for papers by Narendra Wajapeyee Breakdown of academic impact, for papers by Fiona Kaper Breakdown of academic impact, for papers by Georgia Sotiropoulou Breakdown of academic impact, for papers by Maurizio Fanciulli Breakdown of academic impact, for papers by Agata Giallongo Breakdown of academic impact, for papers by Michelle Barton Breakdown of academic impact, for papers by Marco Crescenzi
Rankless by CCL
2026